About
Treatments targeting the formation of neutrophil extracellular traps
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
196
By Phase
PHASE2: 3
By Status
NOT_YET_RECRUITING: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07147959Lead Sponsor
PET-Based Imaging of Radiolabeled CIT-013
PHASE2Not yet recruiting
12 participants
Started: Dec 1, 2025 · Completed: Dec 1, 2026
NCT06993233Lead Sponsor
A Study With CIT-013 in HS Patients
PHASE2Not yet recruiting
96 participants
Started: Sep 30, 2025 · Completed: Jul 31, 2027
NCT06567470Lead Sponsor
A Study With CIT-013 in RA Patients
PHASE2Recruiting
88 participants
Started: Jul 29, 2025 · Completed: Jul 31, 2027
Locations (1)
Headquarters
Oss, Netherlands
Map
Loading map...